Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
Open Access
- 17 December 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 13 (1), 1192
- https://doi.org/10.1186/1471-2458-13-1192
Abstract
Drug-Related Problems (DRPs) commonly occur among type 2 diabetes mellitus (T2DM) patients. However, few studies have been performed on T2DM patients with dyslipidemia. This purpose of this study was to assess drug-related problems (DRPs) and factors associated with its occurrence.Keywords
This publication has 31 references indexed in Scilit:
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- Drug-related problems (DRPs) identified from geriatric medication safety review clinicsArchives of Gerontology and Geriatrics, 2012
- Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature reviewBMC Nephrology, 2011
- Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetesPharmacy World & Science, 2009
- Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)Diabetes Care, 2009
- Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma – interviewing patients at homePharmacy World & Science, 2006
- Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problemsBritish Journal of Clinical Pharmacology, 2006
- Polypharmacy as a Risk Factor in the Treatment of Type 2 DiabetesDiabetes Spectrum, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001